Shares Of Galena Biopharma Plunged On Thursday, Company Announces Public Offering

Shares of

plunged more than 30 percent Thursday morning after the company

a public offering of common stock and warrants. Galena Biopharma, a biopharmaceutical company that focuses on oncology therapeutics, stated on Wednesday afternoon it will offer shares of its common stock and warrants in an underwritten public offering. Galena Biopharma stated it will use the net proceeds to fund its ongoing